Results: Activated immune cells such as macrophages M1, dendritic cells (DCs), innate lymphoid cells (ILC2), NK cells, Th1, follicular T helper cells (TFH), TCD8+, B lymphocytes and eosinophils have inhibitory eklects on tumourigenesis, while tolerogenic cells such as macrophages M2, tolerogenic DCs, ILC3, T and B regulatory lymphocytes appear to through the development of immune checkpoint inhibitors. Already approved by the U.S. Food and Drug Administration for advanced melanoma and non-small cell lung cancer, immune
/Results: Activated immune cells such as macrophages M1, dendritic cells (DCs), innate lymphoid cells (ILC2), NK cells, Th1, follicular T helper cells (TFH), TCD8+, B lymphocytes and eosinophils have inhibitory eklects on tumourigenesis, while tolerogenic cells such as macrophages M2, tolerogenic DCs, ILC3, T and B regulatory lymphocytes appear to